Thụy Sĩ -
Tiếng Ý -
Swissmedic (Swiss Agency for Therapeutic Products)
rivastigmin patch sandoz 5 cerotto transdermico
sandoz pharmaceuticals ag - rivastigminum - cerotto transdermico - rivastigminum 9 mg, butylis methacrylatis et methylis methacrylatis polymerisatum, acrylic adhesive, int-rac-alpha-tocopherolum, silicone adhesive, dimeticonum, trägermaterial: poly(ethylenis terephthalas), drucktinte (beige): ad praeparationem pro 5 cm², cum liberatione 4.6 mg/24h. - demenza di tipo alzheimer - synthetika
Thụy Sĩ -
Tiếng Ý -
Swissmedic (Swiss Agency for Therapeutic Products)
rivastigmin patch sandoz 10 cerotto transdermico
sandoz pharmaceuticals ag - rivastigminum - cerotto transdermico - rivastigminum 18 mg, butylis methacrylatis et methylis methacrylatis polymerisatum, acrylic adhesive, int-rac-alpha-tocopherolum, silicone adhesive, dimeticonum, trägermaterial: poly(ethylenis terephthalas), drucktinte (beige): ad praeparationem pro 10 cm², cum liberatione 9.5 mg/24h. - demenza di tipo alzheimer - synthetika
Thụy Sĩ -
Tiếng Ý -
Swissmedic (Swiss Agency for Therapeutic Products)
rivastigmin patch sandoz 15 cerotto transdermico
sandoz pharmaceuticals ag - rivastigminum - cerotto transdermico - rivastigminum 27 mg, butylis methacrylatis et methylis methacrylatis polymerisatum, acrylic adhesive, int-rac-alpha-tocopherolum, silicone adhesive, dimeticonum, trägermaterial: poly(ethylenis terephthalas), drucktinte (beige): ad praeparationem pro 15 cm², cum liberatione 13.3 mg/24h. - demenza di tipo alzheimer - synthetika
Thụy Sĩ -
Tiếng Ý -
Swissmedic (Swiss Agency for Therapeutic Products)
rivastigmin zentiva patch 13.3 mg/24 h cerotto transdermico
helvepharm ag - rivastigminum - cerotto transdermico - rivastigminum 19.2 mg, excipiens ad praeparationem pro 12.8 cm² cum liberatione 13.3 mg/24h. - demenza di tipo alzheimer - synthetika
Thụy Sĩ -
Tiếng Ý -
Swissmedic (Swiss Agency for Therapeutic Products)
sonovue 8 µl/ml,polvere e solvente per dispersione iniettabile sonovue 8 µl/ml,polvere e solvente per dispersione iniettabile
bracco suisse sa - sulfuris hexafluoridum - sonovue 8 µl/ml,polvere e solvente per dispersione iniettabile - praeparatio cryodesiccata: sulfuris hexafluoridum q.s., macrogolum 4000, distearoylphosphatidylcholinum, 1,2-dipalmitoyl-sn-glycero-3-phospho-rac-glycerolum natricum, acidum palmiticum, pro vitro. solvens: natrii chloridi solutio infundibilis 9 g/l 5 ml. corresp., sulfuris hexafluoridum 45 µg corresp. sulfuris hexafluoridum 8 µl pro 1 ml in suspensione recenter reconstituta. - mezzo di contrasto per l'ultrasonografia - synthetika
Thụy Sĩ -
Tiếng Ý -
Swissmedic (Swiss Agency for Therapeutic Products)
depocyte injektionssuspension
mundipharma medical company, hamilton, bermuda, basel branch - cytarabinum - injektionssuspension - cytarabinum 10 mg, cholesterolum, glyceroli trioleas, natrii dipalmitoylphosphatidylglycerolum, dioleoylphosphatidylcholinum (l-alpha), natrii chloridum, aqua ad iniectabilia q.s. ad suspensionem pro 1 ml. - zytostatikum - synthetika human
Thụy Sĩ -
Tiếng Ý -
Swissmedic (Swiss Agency for Therapeutic Products)
baqsimi 3 mg poudre nasale
eli lilly (suisse) sa - glucagonum - poudre nasale - glucagonum 3 mg, betadexum, dodecylphosphocholinum, ad pulverem. - hypoglycémie sévère - synthetika
Thụy Sĩ -
Tiếng Ý -
Swissmedic (Swiss Agency for Therapeutic Products)
vyxeos liposomal 44 mg/100 mg polvere per concentrato per la preparazione di una infusionsdispersion
jazz pharmaceuticals switzerland gmbh - cytarabinum, daunorubicinum - polvere per concentrato per la preparazione di una infusionsdispersion - cytarabinum 100 mg, daunorubicinum 44 mg, distearoylphosphatidylcholinum, distearoylphosphatidylglycerolum natricum, cholesterolum, cupri(ii) d-gluconas, trolaminum, saccharum, pro vitro. - vyxeos liposomal ist indiziert zur behandlung von erwachsenen mit neu diagnostizierter, therapieassoziierter akuter myeloischer leukämie (t-aml) oder aml mit myelodysplasie-assoziierten veränderungen (aml-mrc). - synthetika